RCUS
Arcus Biosciences, Inc.
$28.19
-0.21%
-0.06
Notify me if price changes either direction
Buy RCUS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.5B
Enterprise value
2.7B
Trailing PE
-8.5699087218311
Forward PE
-9.007819
PEG Ratio
0.81414132857395
Enterprise to EBITDA
-7.035
Enterprise to revenue
11.596
Price to book MRQ
6.6946106
Price to sales TTM
14.895594
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
236.0M
EBITDA
-389000000
Diluted EPS TTM
-3.17
Total Cash (MRQ)
822.0M
Current ratio (MRQ)
4.038
Operating Cash Flow (TTM)
-488000000
RCUS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
August 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
